Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449195) titled 'A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors' on Feb. 27.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Memorial Sloan Kettering Cancer Center
Condition:
Ocular Tumor
Intervention:
Diagnostic Test: Intalight Dream OCT
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: February 27, 2026
Target Sample Size: 60
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07449195
...